CODX vs MMC · rev $3.9M vs P/E 22, rev $24.46B
Co-Diagnostics, Inc. Common Stock (CODX) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
CODX currently screens at market cap $31.4M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the CODX and MMC stock pages for the full models.
Not investment advice.